Novartis Investigative Site

Qingdao, Shandong 266011

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, IgA Nephropathy, Immunoglobulin A Nephropathy, Primary Prevention of Atherosclerotic Cardiovascular Disease, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early